Related Experiment Video
Updated: Oct 14, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis
Weijun Wang1, Wenkang Gao1, Qingjing Zhu2
1Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Chronic insult and persistent injury can cause liver inflammation, fibrosis, and carcinogenesis; it can also be associated with metabolic disorders. Identification of critical molecules that link the process of inflammation and carcinogenesis will provide prospective therapeutic targets for liver diseases. Rapid advancements in gene engineering technology have allowed the elucidation of the underlying mechanism of transformation, from inflammation and metabolic disorders to carcinogenesis. Transforming growth factor-β-activated kinase 1 (TAK1) is an upstream intracellular protein kinase of nuclear factor kappa-B (NF-κB) and c-Jun N-terminal kinases, which are activated by numerous cytokines, growth factors, and microbial products. In this study, we highlighted the functional roles of TAK1 and its interaction with transforming growth factor-β, WNT, AMP-activated protein kinase, and NF-κB signaling pathways in liver inflammation, steatosis, fibrosis, and carcinogenesis based on previously published articles.
Insights
Transforming growth factor-β-activated kinase 1 (TAK1) is crucial in linking liver inflammation, metabolic disorders, and cancer. Understanding TAK1
Area of Science:
- Hepatology and molecular biology, focusing on liver disease pathogenesis.
Background:
- Chronic liver injury can lead to inflammation, fibrosis, and cancer, often linked to metabolic disorders.
- Identifying key molecules connecting inflammation and carcinogenesis is vital for developing new liver disease therapies.
- Transforming growth factor-β-activated kinase 1 (TAK1) is an important intracellular kinase upstream of NF-κB and JNK signaling.
Purpose of the Study:
- To review the functional roles of TAK1 in liver inflammation, steatosis, fibrosis, and carcinogenesis.
- To elucidate TAK1's interactions with TGF-β, WNT, AMPK, and NF-κB signaling pathways.
Main Methods:
- Literature review of published articles on TAK1's role in liver disease.
- Analysis of signaling pathways involving TAK1, TGF-β, WNT, AMPK, and NF-κB.
Main Results:
- TAK1 plays a significant role in mediating liver inflammation, steatosis, fibrosis, and carcinogenesis.
- TAK1 integrates signals from various pathways, including TGF-β, WNT, AMPK, and NF-κB, influencing liver pathology.
Conclusions:
- TAK1 is a critical molecular link between chronic liver injury, inflammation, metabolic dysfunction, and cancer development.
- Targeting TAK1 and its associated signaling pathways offers potential therapeutic strategies for liver diseases.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

